Medical Weight Loss
Compound Semaglutide
Clinically proven weight reduction — supervised, personalized, compound.
Overview
Compound semaglutide is a GLP-1 receptor agonist — a class of medications originally developed for type 2 diabetes that has demonstrated remarkable efficacy in weight management. The compounded version uses the same active peptide formulated by a licensed 503A pharmacy, prescribed and supervised by a licensed clinician for patients with significant weight loss goals.
Administration
Weekly shot (you give it to yourself at home with a tiny needle) or a daily dissolvable tablet that melts under your tongue — your clinician will recommend the best fit based on your goals, tolerance, and preference.
Frequency
Once weekly (shot) with a gradual dose increase over 4–8 weeks, or daily (dissolvable tablet)
Program Track
Medical Weight Loss
Pricing
from $149 /mo
Annual prepay rate · monthly billing $199/mo · all-inclusive
How It Works
How Semaglutide Works
GLP-1 receptors are found in the pancreas, brain, and gut. Semaglutide binds to these receptors, stimulating insulin secretion, suppressing glucagon, slowing gastric emptying, and — critically — reducing appetite by acting on satiety centers in the brain. This combination results in significantly reduced caloric intake and improved glucose regulation, leading to substantial and sustained weight loss.
Benefits
What to expect
Eligibility
Who this program is for
Patients with significant weight loss goals — clinical eligibility is determined individually by your prescribing clinician. This program is medically intensive and requires ongoing clinical supervision. Not appropriate for patients with certain thyroid conditions, pancreatitis history, or other contraindications.
Clinical supervision required. Eligibility for this program is determined by your prescribing clinician based on individual medical history. Not all patients will qualify.
FAQ
Common questions
Is compound semaglutide the same as Ozempic or Wegovy?
Ozempic and Wegovy are brand-name versions of semaglutide from Novo Nordisk. Compound semaglutide uses the same active peptide, formulated by a licensed 503A pharmacy. Compounded versions are not FDA-approved but are legally prescribable by licensed clinicians when commercially manufactured versions are unavailable or inaccessible.
Weekly shot or daily dissolvable tablet — which should I choose?
Both forms deliver the same active peptide. The weekly shot has the most clinical data behind it and generally produces faster, more consistent results. Daily dissolvable tablets (they melt under your tongue) are a needle-free option that many patients prefer for convenience and ease. Your clinician will recommend based on your goals, history, and comfort level — and you can switch forms later if needed.
What are the common side effects?
The most common side effects are nausea, vomiting, constipation, and diarrhea — particularly during dose escalation. These typically subside as the body adjusts. Your clinician will titrate your dose to minimize side effects.
What happens after I reach my goal weight?
Your clinician will develop a maintenance plan with you. Some patients taper to a lower maintenance dose; others transition to peptide wellness programs for ongoing metabolic support. This is planned collaboratively.
Ready to start your Semaglutide program?
Complete a brief online intake — a licensed clinician will review your goals and confirm eligibility.